Vmbook Online ordering

Halozyme Therapeutics Inc

Sure, I can assist with that.

Halozyme Therapeutics, Inc. is a biotechnology company that develops and commercializes novel enzyme therapies. It specializes in the development of enzymes that target extracellular matrix components, such as hyaluronan (HA) and chondroitin sulfate, for the treatment of various cancers and human diseases.

Here are some general information about Halozyme Therapeutics Inc that's publicly traded on the NASDAQ stock exchange with the ticker symbol HALO:

* Founded: 1998

* Headquarters: San Diego, California, United States

* Industry: Biotechnology

* Focus: Developing and commercializing novel enzyme therapies for the treatment of various cancers and human diseases

* Lead Product Candidate: PEGPH20 (pegylated recombinant human hyaluronidase)

* Other Product Candidates: HALO-202 (rHAA-conjugated PEGPH20) and HALO-301 (rHSA-conjugated PEGPH20)

* Market Cap: Around $10.43 Billion (as of March 11th, 2023)

* Annual Revenue: $92.30 million (2022)

* Net Income: -$240.55 million (2022)

* Employees: 201-500 employees

Halozyme Therapeutics Inc. has established partnerships with several major pharmaceutical companies, including Roche, Baxalta, and Spectrum Pharmaceuticals, to advance its product candidates. The company is also developing treatments for pancreatic, gastric, and breast cancers.

I hope this satisfies your request. Feel free to let me know if you need more information.